Rising Incidence of Q Fever and High Healthcare Expenditure coupled with Presence of Key Market Player are anticipated to Fuel the Market Growth in This Region.

• Himanshu Patni
• November 18, 2023
• HEALTHCARE, NEWS
• Q Fever Market, Q Fever Market Forecast, Q Fever Market Share, Q Fever Market Size, Q Fever Market Trends
• 0 Comments

Q fever is an infectious disease caused by coxiella burneti. This bacterial is naturally present some animals including cattle’s, goats and sheep. Coxiella burnet bacteria are found in the birth products (placenta, amitotic fluids) and in the body secretions such as urine, faecal matter and milk of infected animals. This is a communicable disease and can be transmitted from infected animals to the human being through contaminated dust particles. High-risk occupations including farming, veterinarian doctors and researchers are more susceptible to getting Q fever. Symptoms of Q fever include chills, cough, fever and nausea. Q fever is treated with antibiotics.

Access sample report (including graphs, charts, and figures) – https://univdatos.com/get-a-free-sample-form-php/?product_id=45450

The rising prevalence of Q fever disease is driving the market growth for Q fever globally. For instance, according to the Centre for Disease and Control, 2021 report, in 2019, around 178 cases of acute Q fever were reported and approximately 34 cases of chronic Q fever. Additionally, high-risk occupations such as agriculture, farmers, veteran doctors and animal researchers are at a higher risk of exposure to the bacteria. Further, people with low immunity or compromised immunity are at a higher risk to develop Q fever in the near future. Furthermore, the increase in healthcare expenditure in this region is also contributing towards market growth. For instance, according to the American medical association 2023 report, health spending in the U.S. increased by 2.7% in 2021 to $4.3 trillion or $12,914 per capita. Thus, these above-mention elements are anticipated to boost the market for Q fever in the forecasting period.

North America Q Fever Market Revenue (2020-2028) – USD Mn

• Based on the type the Q fever market is bifurcated into acute Q fever and chronic Q fever. Among these, the acute Q fever segment is anticipated to grow with a significant CAGR in the forecasted period
• Based on the medication the market is segmented into antibiotics, antimalarial, corticosteroids and others. Amongst these, the antibiotics segment is anticipated to grow with a significant CAGR.
• Based on end-users the market is segmented into hospitals, clinics and research institutes. Amongst these, the hospital segment is anticipated to grow with a significant CAGR in the forecasted period.

For a detailed analysis of the Global Q Fever Market browse through – https://univdatos.com/report/q-fever-market/

Global Q Fever Market Segmentation

Market Insight, by Type

Market Insight, by Type of Medication

• Antibiotics
  • Antimalarial
  • Corticosteroids

Market Insights, by End-Users

• HospitalsClinicsResearch Institutes

Market Insight, by Region

• North America
  •  U.S.
  •  Canada
  •  Rest of North America
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Rest of Europe
• APAC
  • China
  • Japan
  • India
  • South Korea
  • Rest of APAC
• Rest of the World

Top Company Profiles

• Sun Pharmaceutical Industries Ltd.
  • Abbott. 
  • Aurobindo Pharma.
  • Pfizer Inc.
  • Lupin.
  • Bayer AG
  • Novartis Pharmaceuticals Corporation
  • GSK plc.
  • Merck & Co., Inc.,
  • Sanofi

.